136 related articles for article (PubMed ID: 16789513)
1. [Tumour markers of pancreatic cancer--Part II (molecular markers of carcinogenesis and non-specific tumour markers)].
Groblewska M; Mroczko B; Karpiuk E; Szmitkowski M
Pol Arch Med Wewn; 2005 Nov; 114(5):1118-27. PubMed ID: 16789513
[No Abstract] [Full Text] [Related]
2. Molecular pattern of ductal pancreatic cancer.
Sirivatanauksorn V; Sirivatanauksorn Y; Lemoine NR
Langenbecks Arch Surg; 1998 Apr; 383(2):105-15. PubMed ID: 9641882
[TBL] [Abstract][Full Text] [Related]
3. A human cancer xenograft model utilizing normal pancreatic duct epithelial cells conditionally transformed with defined oncogenes.
Inagawa Y; Yamada K; Yugawa T; Ohno S; Hiraoka N; Esaki M; Shibata T; Aoki K; Saya H; Kiyono T
Carcinogenesis; 2014 Aug; 35(8):1840-6. PubMed ID: 24858378
[TBL] [Abstract][Full Text] [Related]
4. Genetic alterations of K-ras, p53, c-erbB-2, and DPC4 in pancreatic ductal adenocarcinoma and their correlation with patient survival.
Shin SH; Kim SC; Hong SM; Kim YH; Song KB; Park KM; Lee YJ
Pancreas; 2013 Mar; 42(2):216-22. PubMed ID: 23344532
[TBL] [Abstract][Full Text] [Related]
5. Molecular prognostic markers in pancreatic cancer.
Ghaneh P; Kawesha A; Evans JD; Neoptolemos JP
J Hepatobiliary Pancreat Surg; 2002; 9(1):1-11. PubMed ID: 12021893
[TBL] [Abstract][Full Text] [Related]
6. Major molecular markers in pancreatic ductal adenocarcinoma and their roles in screening, diagnosis, prognosis, and treatment.
Singh P; Srinivasan R; Wig JD
Pancreas; 2011 Jul; 40(5):644-52. PubMed ID: 21673535
[TBL] [Abstract][Full Text] [Related]
7. Molecular biology of pancreatic cancer; oncogenes, tumour suppressor genes, growth factors, and their receptors from a clinical perspective.
Sakorafas GH; Tsiotou AG; Tsiotos GG
Cancer Treat Rev; 2000 Feb; 26(1):29-52. PubMed ID: 10660490
[TBL] [Abstract][Full Text] [Related]
8. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
[TBL] [Abstract][Full Text] [Related]
9. Molecular oncology in pancreatic cancer.
Gansauge S; Gansauge F; Beger HG
J Mol Med (Berl); 1996 Jun; 74(6):313-20. PubMed ID: 8862512
[TBL] [Abstract][Full Text] [Related]
10. EVI1 oncogene promotes KRAS pathway through suppression of microRNA-96 in pancreatic carcinogenesis.
Tanaka M; Suzuki HI; Shibahara J; Kunita A; Isagawa T; Yoshimi A; Kurokawa M; Miyazono K; Aburatani H; Ishikawa S; Fukayama M
Oncogene; 2014 May; 33(19):2454-63. PubMed ID: 23752186
[TBL] [Abstract][Full Text] [Related]
11. The acinar regulator Gata6 suppresses KrasG12V-driven pancreatic tumorigenesis in mice.
Martinelli P; Madriles F; Cañamero M; Pau EC; Pozo ND; Guerra C; Real FX
Gut; 2016 Mar; 65(3):476-86. PubMed ID: 25596178
[TBL] [Abstract][Full Text] [Related]
12. [Recent advances in gene change of pancreatic cancer].
Wang YY; Cui QC
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Feb; 26(1):79-82. PubMed ID: 15052782
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic approach to pancreatic tumors with the specimens of endoscopic ultrasound-guided fine needle aspiration.
Hosoda W; Takagi T; Mizuno N; Shimizu Y; Sano T; Yamao K; Yatabe Y
Pathol Int; 2010 May; 60(5):358-64. PubMed ID: 20518885
[TBL] [Abstract][Full Text] [Related]
14. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis.
Qian J; Niu J; Li M; Chiao PJ; Tsao MS
Cancer Res; 2005 Jun; 65(12):5045-53. PubMed ID: 15958547
[TBL] [Abstract][Full Text] [Related]
15. The predictive role of p16 deletion, p53 deletion, and polysomy 9 and 17 in pancreatic ductal adenocarcinoma.
Luo Y; Tian L; Feng Y; Yi M; Chen X; Huang Q
Pathol Oncol Res; 2013 Jan; 19(1):35-40. PubMed ID: 22782330
[TBL] [Abstract][Full Text] [Related]
16. Molecular biology of exocrine pancreatic cancer.
Soto JL; Barbera VM; Saceda M; Carrato A
Clin Transl Oncol; 2006 May; 8(5):306-12. PubMed ID: 16760004
[TBL] [Abstract][Full Text] [Related]
17. Identifying molecular markers for the early detection of pancreatic neoplasia.
Goggins M
Semin Oncol; 2007 Aug; 34(4):303-10. PubMed ID: 17674958
[TBL] [Abstract][Full Text] [Related]
18. Molecular prognostic markers in pancreatic cancer: a systematic review.
Garcea G; Neal CP; Pattenden CJ; Steward WP; Berry DP
Eur J Cancer; 2005 Oct; 41(15):2213-36. PubMed ID: 16146690
[TBL] [Abstract][Full Text] [Related]
19. The discrete nature and distinguishing molecular features of pancreatic intraductal tubulopapillary neoplasms and intraductal papillary mucinous neoplasms of the gastric type, pyloric gland variant.
Yamaguchi H; Kuboki Y; Hatori T; Yamamoto M; Shimizu K; Shiratori K; Shibata N; Shimizu M; Furukawa T
J Pathol; 2013 Nov; 231(3):335-41. PubMed ID: 23893889
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic NRG1 Fusions: A New Hope for Targeted Therapy in Pancreatic Cancer.
Aguirre AJ
Clin Cancer Res; 2019 Aug; 25(15):4589-4591. PubMed ID: 31164372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
